Byline: Christopher Knox
AMEDICAL diagnostics supply company that helps reduce the risk of patients rejecting donated organs, expects to increase its turnover after securing another supply contract with the National Blood Service.
Gateshead-based company VH Bio was set up in 1992 to supply the healthcare industry with diagnostic kits and reagents to help match donor organs to recipient patients.
VH Bio is the exclusive UK and Ireland distributor of the kits, which are manufactured in Los Angeles in the US.
The company has grown yearon-year and saw its profits rise by about 80% to pounds 1.1m in the year to March 31, 2009 after securing a second tender to supply the National Health Service Blood and Transplant Authority.
Over the past few years it has grown its market share considerably and now estimates it has over 60% of the UK market for transplant diagnostics, with a turnover of pounds 7.4m for the year 2010/2011.
The company, which employs 14 staff, is now expecting to grow its sales to pounds 8m for the year 2011-12.
The company recently began supplying diagnostic kits from US medical diagnostics company Asuragen, which specialises in kits which detect fragile X mental retardation (FMR1) genes in human DNA.
While 80% of its work is with the NHS, the firm is also heavily involved with university science labs across the country, providing a range of kits and reagents for a variety of molecular biology research projects.
The company, which has customers in the UK and Ireland, continues to supply its technology to leukaemia charity The Anthony Nolan Trust, which is used to match bone marrow from patient to patient. …